| Report ID |
59142 |
| Drug Identification Number |
02468425 |
| Brand name |
SHINGRIX |
| Common or Proper name |
Herpes Zoster vaccine |
| Company Name |
GLAXOSMITHKLINE INC |
| Market Status |
MARKETED |
| Active Ingredient(s) |
VARICELLA-ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN |
| Strength(s) |
50MCG |
| Dosage form(s) |
SUSPENSION |
| Route of administration |
INTRAMUSCULAR |
| Packaging size |
1's |
| ATC code |
J07BK |
| ATC description |
|
| Reason for shortage |
Other (Please describe in comments) |
| Anticipated start date |
|
| Actual start date |
2018-08-24 |
| Estimated end date |
|
| Actual end date |
2020-06-17 |
| Shortage status |
Resolved |
| Updated date |
2020-06-18 |
| Company comments |
High demand for the drug coupled with the variable timing of supply shipments. Re-supply is ongoing with current inventory on allocation. |
| Health Canada comments |
|
| Tier 3 Status |
No |
| Company contact information |
1-800-387-7374 |
